MENA Leaders Advocate for Housing Policies Beyond Construction at Baku Forum Stolen Identities Emerge as Primary Driver of Cyberattack Surge Ferrari Shares Slide After Luxury Carmaker Unveils First Fully Electric Vehicle ICRA Flags Sharp Decline in IBC Recovery Rates to 22 in H2 FY26 Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Micron Dicks Earnings and Texas Primary Key Market Movers in CNBCs Morning Squawk UGI Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Resilience ARI Q1 2026 Earnings EPS Misses Estimates as Net Interest Income Pressures Continue DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline PUK Q4 2025 Earnings EPS Misses Estimates by 2917 Amid Market Headwinds LYG Q1 2026 Earnings Strong Earnings Beat Despite Stock Decline ESLT Q4 2025 Earnings EPS Surges Past Expectations Amid Strong Defense Demand Mammoth Energy Services TUSK Slides 47 as Selling Pressure Persists Key Support Levels in Focus LATAM Airlines LTM Dips Over 2 Navigating Resistance and Support Levels Plains GP Holdings Pushes Higher on Strong Session PAGP Climbs 172 NextEra Energy NEE Slides 127 as Utility Sector Faces Headwinds Support Levels in Focus Linkage Global Inc LGCB Holds Steady Near Support as Traders Assess MicroCap Dynamics New York Fed Study Reveals LowerIncome Households Bear the Brunt of Rising Gas Prices IMOS Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Industry Uncertainty Hain Celestial Stock Surges 10 as Shares Break Above Key Moving Averages LIXT Q4 2024 Earnings PreRevenue Biotech Reports PerShare Loss as Stock Jumps 136 Catheter Precision VTAK Q1 2025 Earnings Significant EPS Miss as Stock Rises Amid Strategic Progress ORGN Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Business Restructuring Bridgewater Bancshares BWB Q1 2026 Earnings Marginal EPS Miss Amid Positive Market Response TRC Q1 2026 Earnings Profitability Surprise as EPS Beats Estimates by 1495 POCI Q1 2026 Earnings Narrowing Loss Amidst Operational Progress Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue